Secondary Schizophrenia (95 page)

238

Chapter 17 – Mitochondrial disorders and psychosis

References

and DiMauro S.,
et al.
(Eds.).

19. Iizuka T., Sakai F. Pathogenesis of

Philadelphia: Butterworth

strokelike episodes in MELAS:

1. Schon E. A. (2003). The

Heinemann.

analysis of neurovascular cellular

mitochondrial genome. In The

mechanisms. Curr Neurovasc Res,

Molecular and Genetic Basis of

10. Goldstein J. M., Faraone S. V.,

2005.
2
(1):29–45.

Neurologic and Psychiatric

Chen W. J.,
et al.
Sex differences in
Disease, Rosenberg R. N.,

the familial transmission of

20. Scaglia F., Northrop J. L. The

Prusiner S. B. and DiMauro S.,

schizophrenia. Br J Psychiatry,

mitochondrial myopathy

et al.
(Eds.). Philadelphia:

1990.
156
:819–26.

encephalopathy, lactic acidosis

Butterworth Heinemann.

11. Shimizu A., Kurachi M.,

with strokelike episodes

(MELAS) syndrome – a review of

2. Chinnery P. F., Schon E. A.

Yamaguchi N.,
et al.
Morbidity

treatment options. CNS Drugs,

Mitochondria. J Neurol Neurosurg

risk of schizophrenia to parents

2006.
20
(6):443–64.

Psychiatry, 2003.
74
:1188–99.

and siblings of schizophrenic

patients. Jap J Psychiatr Neurol,

21. Kovacs G. G., Hoftberger R.,

3. Giles R. E., Blanc H., Cann H. M.,

1987.
41
(1):65–70.

Majtenyi K.,
et al.
Neuropathology

et al.
Maternal inheritance of

of white matter disease in

human mitochondrial-DNA. Proc

12. Whatley S. A., Curti D.,

Leber’s hereditary optic

Natl Acad Sci USA, 1980.
77
(11):
Marchbanks R. M. Mitochondrial

neuropathy. Brain, 2005.

6715–19.

involvement in schizophrenia and

other functional psychoses.

128
(Pt 1):35–41.

4. Sutovsky P., Moreno, R. D.,

Neurochem Res, 1996.
21
(9):
22. Fattal O., Budur K., Vaughan A. J.,

Ramalho-Santos J.,
et al.

995–1004.

et al.
Review of the literature on

Development – Ubiquitin tag for

13. Cavelier L., Jazin E. E., Eriksson I.,

major mental disorders in adult

sperm mitochondria. Nature,

et al.
Decreased cytochrome-c

patients with mitochondrial

1999.
402
(6760):371–2.

oxidase activity and lack of

diseases. Psychosomatics, 2006.

5. Finsterer J. Central nervous

age-related accumulation of

47
(1):1–7.

system manifestations of

mitochondrial DNA deletions in

23. Mizukami K., Sasaki M., Suzuki

mitochondrial disorders. Acta

the brains of schizophrenics.

T.,
et al.
Central nervous system

Neurol Scand, 2006.
114
:
Genomics, 1995.
29
(1):217–24.

changes in mitochondrial

217–38.

14. King L., Roberts R. C.

encephalomyopathy: light and

6. Chinnery P. E., Howell N.,

Mitochondrial pathology in

electron microscopic study. Acta

Lightowlers R. N.,
et al.
MELAS

human schizophrenic striatum: a

Neuropathol (Berl), 1992.

and MERRF – The relationship

postmortem ultrastructural study.

83
(4):449–52.

between maternal mutation load

Synapse, 1999.
31
(1):67–75.

24. Suzuki T., Koizumi J., Shiraishi

and the frequency of clinically

15. Martorell L., Segues T., Folch G.,

H.,
et al.
Psychiatric disturbance

affected offspring. Brain, 1998.

et al.
New variants in the

in mitochondrial

121
:1889–94.

mitochondrial genomes of

encephalomyopathy. J Neurol

7. DiMauro S. E. B. (2003).

schizophrenic patients. Eur J Hum

Neurosurg Psychiatry, 1989.

Mitochondrial disorders due to

Genet, 2006.
14
(5):520–8.

52
(7):920–2.

mutations in the mitochondrial

16. Odawara M., Arinami T., Tachi Y.,

25. Suzuki Y., Taniyama M.,

genome. In The Molecular and

et al.
Absence of association

Muramatsu T.,
et al.
Diabetes

Genetic Basis of Neurologic and

between a mitochondrial DNA

mellitus associated with 3243

Psychiatric Disease, Rosenberg R.

mutation at nucleotide position

mitochondrial tRNA(Leu(UUR))

N., Prusiner S. B., and DiMauro

3243 and schizophrenia in

mutation: clinical features and

S.,
et al.
(Eds.). Philadelphia:

Japanese. Hum Genet, 1998.

coenzyme Q10 treatment. Mol

Butterworth Heinemann.

102
(6):708–9.

Aspects Med, 1997.
18
(Suppl):
8. Servidei S. Mitochondrial

17. Janssen R., Nijtmans L. G., Van

S181–8.

encephalomyopathies:gene

Den Heuvel L. P.,
et al.

26. Yamazaki M., Igarashi H.,

mutation. Neuromusc Disord:

Mitochondrial complex I:

Hamamoto M.,
et al.
A case of

NMD, 2002.
12
(5):524.

structure, function and pathology.

mitochondrial

9. Hirano M. (2003). Mitochondrial

J Inherit Metab Dis, 2006.
29
(4):
encephalomyopathy with

disorders due to mutations in the

499–515.

schizophrenic psychosis,

nuclear genome. In The Molecular

18. Abe K. Cerebral lactic acidosis

dementia and neuroleptic

and Genetic Basis of Neurologic

correlates with neurological

malignant syndrome. Rinsho

and Psychiatric Disease,

impairment in MELAS.

Shinkeigaku, 1991.
31
(11):
239

Rosenberg R. N., Prusiner S. B.,

Neurology, 2004.
63
(12):2458.

1219–23.

Organic Syndromes of Schizophrenia – Section 3

27. Jaksch M., Lochmuller H.,

Neurosurg Psychiatry, 1998.

40. Domenech E., Gomez-Zaera M.,

Schmitt F.,
et al.
A mutation in mt

64
(5):692–3.

Nunes V. Wolfram/DIDMOAD

tRNALeu(UUR) causing a

34. Odawara M., Isaka M., Tada K.,

syndrome, a heterogenic and

neuropsychiatric syndrome with

et al.
Diabetes mellitus associated

molecularly complex

depression and cataract.

with mitochondrial myopathy and

neurodegenerative disease.

Neurology, 2001.
57
(10):
schizophrenia: a possible link

Pediatr Endocrinol Rev, 2006.

1930.

between diabetes mellitus and

3
(3):249–57.

28. Amemiya S., Hamamoto M., Goto

schizophrenia. Diabet Med, 1997.

41. Barrientos A., Volpini V.,

Y.,
et al.
Psychosis and progressing

14
(6):503.

Casademont J.,
et al.
A nuclear

dementia: presenting features of a

35. Kaido M., Fujimura H., Soga F.,

defect in the 4p16 region

mitochondriopathy. Neurology,

et al.
Alzheimer-type pathology in

predisposes to multiple

2000.
55
(4):600–1.

a patient with mitochondrial

mitochondrial DNA deletions in

29. Inagaki T., Ishino H., Seno H.,

myopathy, encephalopathy, lactic

families with Wolfram syndrome.

et al.
Psychiatric symptoms in a

acidosis and strokelike episodes

J Clin Invest, 1996.
97
(7):1570–6.

patient with diabetes mellitus

(MELAS). Acta Neuropathol

42. Swift R. G., Perkins D. O., Chase

associated with point mutation in

(Berl), 1996.
92
(3):312–8.

C. L.,
et al.
Psychiatric disorders

mitochondrial DNA. Biol

36. Apostolova L. G., White M.,

in 36 families with Wolfram

Psychiatry, 1997.
42
(11):1067–9.

Moore S. A.,
et al.
Deep white

syndrome. Am J Psychiatry, 1991.

30. Prayson R. A., Wang N.

matter pathologic features in

148
(6):775–9.

Mitochondrial myopathy,

watershed regions: a novel pattern

43. Shinkai T., Nakashima M.,

encephalopathy, lactic acidosis,

of central nervous system

Ohmori O.,
et al.
Coenzyme Q10

and strokelike episodes (MELAS)

involvement in MELAS. Arch

improves psychiatric symptoms in

syndrome: an autopsy report.

Neurol, 2005.
62
(7):
adult-onset mitochondrial

Arch Pathol Lab Med, 1998.

1154–6.

myopathy, encephalopathy, lactic

122
(11):978–81.

37. Campos Y., Garcia A., Eiris J.,

acidosis and strokelike episodes:

31. Spellberg B., Carroll R. M.,

et al.
Mitochondrial myopathy,

a case report. Aust NZ J

Robinson E.,
et al.
mtDNA disease

cardiomyopathy and psychiatric

Psychiatry, 2000.
34
:1034–5.

in the primary care setting. Arch

illness in a Spanish family

44. Lambert T. J., Velakoulis D.,

Intern Med, 2001.
161
(20):
harbouring the mtDNA 3303C >

Pantelis C. Medical comorbidity

2497–500.

T mutation. J Inherit Metab Dis,

in schizophrenia. Med J Aust,

32. Saijo T, Naito E, Ito M,
et al.

2001.
24
(6):685–7.

2003. 178 Suppl:S67–70.

Therapeutic effect of sodium

38. Ueda Y., Ando A., Nagata T.,
et al.

45. Fendri C., Mechri A., Khiari G.,

dichloroacetate on visual and

A boy with mitochondrial disease:

et al.
Oxidative stress involvement

auditory hallucinations in a

asymptomatic proteinuria without

in schizophrenia

patient with MELAS.

neuromyopathy. Pediatr Nephrol,

pathophysiology: a review.

Neuropediatrics, 1991.

2004.
19
(1):107–10.

Encephale, 2006.
32
(2 Pt
22
(3):166–7.

39. Polymeropoulos M. H., Swift R.

1):244–52.

33. Thomeer E. C., Verhoeven W. M.

G., Swift M. Linkage of the gene

46. Szeto H. H. Mitochondria-

A., Van De Vlasakker C. J. W.,

for Wolfram syndrome to markers

targeted peptide antioxidants:

et al.
Psychiatric symptoms in

on the short arm of chromosome

novel neuroprotective agents.

MELAS; a case report. J Neurol

4. Nat Genet, 1994.
8
(1):95–7.

AAPS J, 2006.
8
(3):E521–31.

240

Section 3

Organic syndromes of schizophrenia: other neurological disorders

Patricia I. Rosebush, Rebecca Anglin, and Michael Mazurek
Facts box

cortical interactions? In this case, one might expect the
r

result to be a disturbance of mental function. In other
Inherited leukodystrophies are under

words, a leukodystrophy that targets the white mat-recognized and under diagnosed in
ter of the brain will tend to produce psychiatric symp-psychiatric populations.